Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 In human astrocytomas appear related to malignancy grade

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 8, 1999, Pages 881-885

  Ino, Yasushi ^a   Silver, Jonathan S ^a   Blazejewski, Lisa ^a   Nishikawa, Ryo ^b   Matsutani, Masao ^b   Von Deimling, Andreas ^c   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SAITAMA UNIVERSITY   (Japan)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Astrocytoma; Chromosome 22q; Glioblastoma; Tumor suppressor gene

Indexed keywords

ARTICLE; ASTROCYTOMA; CANCER GRADING; CARCINOGENESIS; CHROMOSOME 22Q; CHROMOSOME DELETION; DISEASE ASSOCIATION; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0032809735     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199908000-00010     Document Type: Article

References (21)

1. Louis DN, Cavenee WK. Molecular biology of central nervous system tumors. In: DeVita VT, Hellman S, Rosenberg SA. eds. Cancer: Principles and practice of oncology. Philadelphia: Lippincott-Raven, 1997
2. De Vitis LR, Tedde A, Vitelli F, et al. Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin. Hum Genet 1996;97:638-41
3. Hoang-Xuan K, Merel P, Vega F, et al. Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Int J Cancer 1995;60:478-81
4. Rubio MP, Correa KM, Ramesh V, et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 1994;54:45-47
5. Allione F, Eisinger F, Pare P, Noguchi T, Sobol H, Birnbaum D. Loss of heterozygosity at loci from chromosome arm 22q in human sporadic breast carcinomas. Int J Cancer 1998;75:181-86
6. Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD, Campbell IG. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res 1996;56:719-21
7. Iida A, Kurose K, Isobe R, et al. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer 1998;21:108-12
8. Miyakawa A, Wang XL, Nakanishi H, et al. Allelic loss on chromosome 22 in oral cancer: Possibility of the existence of a tumor suppressor gene on 22q13. Int J Oncol 1998;13:705-9
9. Takahashi K, Kudo J, Ishibashi H, Hirata Y, Niho Y. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology 1993;17:794-99
10. Yana I, Kurahashi H, Nakamori S, et al. Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers. Int J Cancer 1995;60:174-77
11. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998;394:203-6
12. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. Berlin: Springer-Verlag, 1993
13. Louis DN, von Deimling A, Seizinger BR. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 1992;141: 777-82
14. Rosenberg JE, Lisle DK, Burwick JA, et al. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 1996;13:2483-85
15. Rey JA, Bello MJ, Jimenez-Lara AM, et al. Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer 1992;51: 703-6
16. Karlbom AE, James CD, Boethius J, et al. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 1993;92:169-74
17. Diedrich U, Lucius J, Bittermann HJ, et al. Loss of alleles in brain tumours: Distribution and correlations with clinical course. J Neurol 1995;242:707-11
18. von Deimling A, Bender B, Jahnke R, et al. Loci associated with malignant progression in astrocytomas: A candidate on chromosome 19q. Cancer Res 1994;54:1397-401
19. Burger PC, Yu IT, Tihan T, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A pediatric oncology group study. Am J Surg Pathol 1998;22:1083-92
20. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity. J Neurosurg 1996;85:56-65
21. Muhammad AK, Yoshimine T, Maruno M, Tokiyoshi K, Takemoto O, Hayakawa T. Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors. Neurol Med Chir (Tokyo) 1997;37: 606-10